ALSO NOTED: Program eliminates polio in Somalia; New insight into malaria vaccine; and much more...

Vaccine Market

A group of 10,000 volunteers and health workers has eliminated polio in Somalia through an ambitious vaccination program. And workers say the experience could help officials eradicate the disease in other troubled parts of the world. Report

Scottish officials say they're lagging behind international targets set for MMR vaccines. Story

Since the approval of a vaccine against pneumococcal bacteria for young children in 2000, rates of invasive pneumococcal disease are down significantly in all age groups, while rates of IPD caused by non-vaccine strains are modestly on the rise. Release

A group of U.S. territories and small island states in the Pacific are being given 30,000 surplus doses of flu vaccine by the U.S. military. Report

Vaccine Research

A key insight by a team of international scientists into the reproductive process may provide a critical piece of information that can be used to develop a new malaria vaccine. The parasite that causes malaria uses the same two-step process seen in reproduction, and when that process is interrupted, the disease is halted. Release

Researchers at UNC say that an inhaled tuberculosis vaccine is as effective as the injectable kind and is also easier to store and administer. Story

Researchers in Colombia, South America, describe a new strategy for designing the next generation of synthetic vaccines that could lead to more effective treatments for fighting malaria, tuberculosis, AIDS and other infectious diseases. These conditions kill more than 17 million people around the world each year. Release

ImmuneRegen BioSciences has forged a partnership with DelSite Biotechnologies to develop a new vaccine adjuvant system. Release

Dutch biotechnology company Crucell N.V. announced a non-exclusive research license agreement with biopharmaceutical company Medarex for the production of monoclonal antibodies. Financial details of the agreement were not disclosed. Release

Medicago announced that its H5N1 vaccine made from the Indonesian strain provided 100 percent protection in mice. The company has now established that its lead vaccine has the potential to protect against three of the deadliest strains of pandemic influenza. Release

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.